Download PDF
Thromb Haemost 1989; 62(04): 1146
DOI: 10.1055/s-0038-1647134
Letter to the Editor
Schattauer GmbH Stuttgart

Extrinsic Coagulation Pathway Inhibitor during Recombinant Factor VIIa Infusion

Per Morten Sandset
1   Department of Medicine, Aker University Hospital, 0514 Oslo 5, Norway
,
Ulrich Abildgaard
1   Department of Medicine, Aker University Hospital, 0514 Oslo 5, Norway
,
Ulla Hedner
2   NOVO Research Institute, Bagsvaerd, Denmark
,
Hans Johansson
3   Department of Medicine, Karolinska Hospital, Stockholm, Sweden
› Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Sanders NL, Bajaj P, Zivelin A, Rapaport SI. Inhibition of tissue factor/factor VII in plasmarequires factor X and an additional plasma component. Blood 1985; 66: 204-212
    PubMedGoogle Scholar
  • 2 Hubbard AR, Jennings CA. Inhibition of the tissue factorfactor VII complex: Involvement of factor Xa and lipoproteins. Thromb Res 1987; 46: 527-537
    CrossrefPubMedGoogle Scholar
  • 3 Broze GJ, Miletich JP. Characterization of the inhibition of tissue factor in serum. Blood 1987; 69: 150-155
    PubMedGoogle Scholar
  • 4 Sandset PM, Abildgaard U, Pettersen M. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res 1987; 47: 389-400
    CrossrefPubMedGoogle Scholar
  • 5 Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci 1977; 74: 5260-5264
    CrossrefPubMedGoogle Scholar
  • 6 Broze GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight in to its possible mechanism of action. Blood 1988; 71: 335-343
    PubMedGoogle Scholar
  • 7 Warn-Cramer BJ, Rao L VM, Maki SL, Rapaport SI. Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: Evidence for a two-step model of inhibition. Thromb Haemostas 1988; 60: 453-456
    PubMedGoogle Scholar
  • 8 Redner U, Glazer S, Pingel K, Alberts KA, Blombäck M, Schulman S, Johnsson H. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy. Lancet 1988; 2: 1193
    PubMedGoogle Scholar
  • 9 Seligsohn U, Kasper CK, Østerud B, Rapaport SI. Activated factor VII: Presence in factor IX concentrate and persistence in the circulation after infusion. Blood 1978; 53: 828-837
    PubMedGoogle Scholar